Literature DB >> 34977250

Corrigendum to "Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis".

Wenjing Wang1,2,3, Shubin Niu4, Luxin Qiao1,2,3, Feili Wei1,2,3, Jiming Yin1,2,3, Shanshan Wang1,2,3, Yabo Ouyang1,2,3, Dexi Chen1,2,3.   

Abstract

[This corrects the article DOI: 10.1155/2019/8727935.].
Copyright © 2021 Wenjing Wang et al.

Entities:  

Year:  2021        PMID： 34977250      PMCID： PMC8716220          DOI： 10.1155/2021/9808613

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


The article titled “Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis” [1] contains a figure duplication in Figures 2 and 1, which was raised on PubPeer [2]. Specifically, Figure 2(c) panel UA + Adr overlaps with Figure 1(c) panel UA + Adr. The authors state that this was due to the incorrect file being selected during the preparation of the figure. The correct Figure 1(c) is as below.
Figure 1
  1 in total

1.  Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis.

Authors:  Wenjing Wang; Shubin Niu; Luxin Qiao; Feili Wei; Jiming Yin; Shanshan Wang; Yabo Ouyang; Dexi Chen
Journal:  Biomed Res Int       Date:  2019-02-11       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.